Singleton Hospital is a general hospital in Sketty Lane, Swansea, Wales. It is managed by Swansea Bay University Health Board.

There are 550 beds in South West Wales Cancer Institute.

During the past decade, South West Wales Cancer Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South West Wales Cancer Institute" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "University College, London" with 2 trials sponsored, "University of Leeds" with 2 trials sponsored, "Anglo Celtic Cooperative Oncology Group" with 1 trials sponsored and "Aravive, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South West Wales Cancer Institute" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "University of Sheffield" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "South West Wales Cancer Institute" are "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (4 trials), "Primary Peritoneal Cavity Cancer" (4 trials), "Breast Cancer" (3 trials) and "Metastatic Cancer" (3 trials). Many other conditions were trialed in "South West Wales Cancer Institute" in a lesser frequency.

Most popular intervention types in "South West Wales Cancer Institute" are "Drug" (15 trials), "Biological" (6 trials), "Procedure" (6 trials), "Other" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "adjuvant therapy" (2 trials), "erlotinib hydrochloride" (2 trials), "neoadjuvant therapy" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "South West Wales Cancer Institute" are 10 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "South West Wales Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in South West Wales Cancer Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in South West Wales Cancer Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".